Heart Failure Seoul 2025.

2022 Annual Scientific Meeting of the Korean Society of Heart Failure

Detailed Program

Current Page: Program > Detailed Program

English Session

Korean Session

Day 1 - Thu, Sep 11
Room B Learning Objective + Session Rationale +
09:00-10:20	ENG Inflammatory Heart Disease, Burning Heart	Dae-Gyun Park (Hallym Univ., Korea) , Barry Greenberg (Univ. of California San Diego, USA)
This session aims to develop a comprehensive understanding of the diagnosis, treatment, and management of inflammatory heart disease—including myocarditis, pericarditis, cardiac sarcoidosis, and drug-induced cardiotoxicity—by highlighting current insights, therapeutic innovations, and real-world clinical practices.
Inflammatory heart disease still feels unfamiliar and challenging. Let us undertake a comprehensive review of the most commonly encountered forms of inflammatory heart disease: myocarditis, pericarditis, cardiac sarcoidosis, and drug-induced cardiotoxicity.
09:00-09:15	Current Insights in Myocarditis: Diagnosis and Treatment Updates		Kye Hun Kim (Chonnam National Univ., Korea)
09:15-09:30	Pericarditis, from Etiology to Effective Treatment		Eui-Young Choi (Yonsei Univ., Korea)
09:30-09:45	Innovations in the Diagnosis and Treatment of Cardiac Sarcoidosis		Takeshi Kitai (National Cerebral and Cardiovascular Center, Japan)
09:45-10:00	Drug-induced Inflammatory Heart Disease in Real Clinical Practice		Jae Yeong Cho (Chonnam National Univ., Korea)
10:00-10:20	Discussion		Jun-Bean Park (Seoul National Univ., Korea) , SungA Bae (Yonsei Univ., Korea) , Taeil Yang (Gachon Univ., Korea) , Ji-Won Hwang (Inje Univ., Korea)

Room B Learning Objective + Session Rationale +
10:30-11:50	ENG [Joint Session with KSSO] The Present and Future Management of Obesity	Seok Min Kang (Yonsei Univ., Korea) , Min-Seon Kim (Ulsan Univ., Endocrinology and Metabolism, Korea)
This session aims to build a comprehensive understanding of obesity and its broad clinical implications, with a particular focus on its pathophysiologic and therapeutic relevance to heart failure. Through a multidisciplinary approach, the session will explore up-to-date strategies for obesity treatment, including emerging concepts in the management of obese heart failure.
Obesity is a disease—and in patients with heart failure, it becomes an even more serious condition. This joint session with KSSO is structured to provide an integrated view of obesity from both endocrinology and cardiology perspectives. The alternating structure of endocrinology and cardiology topics is designed to encourage multidisciplinary insights and foster clinical collaboration.
10:30-10:45	Why Do We Treat Obesity? - The Current and Future Threat of Obesity		Yang Im Hur (CHA Univ., Family Medicine, Korea)
10:45-11:00	Obesity and Heart Failure - Pathophysiologic Links and Effects of Anti-obesity Treatment		Gianluigi Savarese (Karolinska Institutet, Sweden)
11:00-11:15	Current and Emerging Medications for Obesity Management - Step by Step Guidance		Jang Won Son (The Catholic Univ., Endocrinology and Metabolism, Korea)
11:15-11:30	NuSH and Other Treatment Options in the Management of Obese Heart Failure		Chan Joo Lee (Yonsei Univ., Korea)
11:30-11:50	Discussion		Seo Young Kang (Eulji Univ. ,Family Medicine, Korea) , Minjoo Kim (Hannam Univ., Food and Nutrition, Korea) , Sang Min Park (Eulji Univ., Korea) , Jung Woo Son (Yonsei Wonju Univ., Korea)

Room B
12:10-12:40	ENG Opening Ceremony

Room B
12:40-13:40	ENG Luncheon Session 2 Advancing Quality in Heart Failure: Entresto at the Core	Byung Su Yoo (Yonsei Wonju Univ., Korea)
12:40-13:40	Overcoming Clinical Inertia: Optimizing Sacubitril/Valsartan and GDMT for Heart Failure with a Need for Speed		Stephen Greene (Duke Univ., USA)

Room B Learning Objective + Session Rationale +
13:40-15:00	ENG [Joint Session with HFSA] A Fresh Look on Cardiovascular Kidney Metabolic Syndrome	Byung Su Yoo (Yonsei Wonju Univ., Korea) , Barry Greenberg (Univ. of California San Diego, USA)
This session aims to provide a comprehensive understanding of the Cardiovascular Kidney Metabolic (CKM) Syndrome.
This joint session with the Heart Failure Society of America (HFSA) revisits the evolving concept of Cardiovascular Kidney Metabolic (CKM) syndrome, which highlights the complex and bidirectional interplay between cardiovascular, renal, and metabolic dysfunction in heart failure.
13:40-14:00	Pathophysiology and Risk Staging of CKM Syndrome		Stephen Greene (Duke Univ., USA)
14:00-14:20	Trends in the Prevalence of CKM Syndrome in Korean HF Patients		Jin Joo Park (Seoul National Univ., Korea)
14:20-14:40	Treatment for Advanced CKM Syndrome: Present and Future		Stephen Greene (Duke Univ., USA)
14:40-15:00	Discussion		Min-Seok Kim (Ulsan Univ., Korea) , Sung-Hee Shin (Inha Univ., Korea) , Chan Joo Lee (Yonsei Univ., Korea)

Room B Learning Objective + Session Rationale +
15:20-16:40	ENG [Joint Session with JHFS] ATTR Amyloidosis	Jin-Oh Choi (Sungkyunkwan Univ., Korea) , Koichiro Kinugawa (Univ. of Toyama, Japan)
This session aims to deepen understanding of transthyretin amyloid cardiomyopathy (ATTR-CM) in Asian populations by addressing challenges in diagnosis, regional clinical characteristics, novel imaging techniques, and real-world treatment outcomes.
This joint session with the Japanese Heart Failure Society (JHFS) highlights the importance of recognizing and managing transthyretin amyloid cardiomyopathy (ATTR-CM) in Asian populations, where clinical awareness and diagnostic access are still evolving.
15:20-15:35	Patient Journey to Diagnosis of ATTR Cardiomyopathy in Asian Population		Jin Endo (Keio Univ., Japan)
15:35-15:50	Diagnostic Pitfall and Clinical Characteristics of ATTR Cardiomyopathy in Asian Population		Darae Kim (Sungkyunkwan Univ., Korea)
15:50-16:05	Novel Imaging for Diagnosis and Follow-up of ATTR Cardiomyopathy		Yasuhiro Izumiya (Kumamoto Univ., Japan)
16:05-16:20	Real-world Treatment and Prognosis of ATTR Cardiomyopathy		Jaewon Oh (Yonsei Univ., Korea)
16:20-16:40	Discussion		Kyu-Yong Ko (Inje Univ., Korea) , Ji-Hyun Kim (The Catholic Univ., Korea) , Jong-Chan Youn (The Catholic Univ., Korea) , Hyemoon Chung (Kyung Hee Univ., Korea)

Room B Learning Objective + Session Rationale +
16:40-18:00	ENG Focus on Heart Failure in Women	Myung-A Kim (Seoul National Univ., Korea) , Mi-Seung Shin (Gachon Univ., Korea)
This session aims to enhance awareness and understanding of the unique burden, risk factors, and pathophysiological characteristics of heart failure in women, and to explore sex-specific approaches to cardiovascular risk assessment, management, and genetic cardiomyopathies.
Despite increasing recognition, heart failure in women remains underdiagnosed and undertreated, with sex-specific factors contributing to disparities in care and outcomes. This session highlights recent advances and expert perspectives on addressing these gaps.
16:40-17:00	The Disproportionate Burden of Heart Failure in Women: Advances and Expert Perspectives		Barry Greenberg (Univ. of California San Diego, USA)
17:00-17:20	Women Specific Cardiovascular Risk and Management		Seong-Mi Park (Korea Univ., Korea)
17:20-17:40	Sex Differences in Genetic Cardiomyopathy		Sung-Hee Shin (Inha Univ., Korea)
17:40-18:00	Discussion		Jung Woo Son (Yonsei Wonju Univ., Korea) , Mi-Hyang Jung (The Catholic Univ., Korea) , In-Jeong Cho (Ewha Womans Univ., Korea)

Program